← Founder Radar · Category
Biotech Pharma
90-day signals
2
Total funded
$15.4M
Launches
0
14-day momentum
Peptris raised ₹7.7M Series A from IAN Alpha Fund to scale AI-led drug discovery. Preclinical automation via ML is attracting early-stage capital; Peptris targets molecule screening acceleration. Gap: clinical trial data standardization and regulatory pathway clarity remain fragmented across geographies.
Get the weekly deep dive in your inbox
Every Sunday, we go three levels deep on the strongest pattern of the week — competitive density, pricing benchmarks, and the underserved edge.
Thanks — you're on the list. See you Sunday.
No spam. Unsubscribe anytime. One email a week.